Nature Medicine, Published online: 26 September 2025; doi:10.1038/s41591-025-03952-9
Despite mixed efficacy outcomes, a phase 1/2 umbrella trial brings the glioblastoma field closer to a new era of diagnostic precision and targeted therapy.
Nature Medicine, Published online: 26 September 2025; doi:10.1038/s41591-025-03952-9
Despite mixed efficacy outcomes, a phase 1/2 umbrella trial brings the glioblastoma field closer to a new era of diagnostic precision and targeted therapy.
SoCalTreatmentServices.com Reaffirms Commitment to Comprehensive Addiction &
New Colorado Bill Protects Beavers to Reduce
Renewable energy – powering a safer and
Humann and Texas Athletics Bring Heart Health
Sorry, the comment form is closed at this time.
